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Objetivo: Comparar las concentraciones de lípidos y li-
poproteínas plasmáticas en neonatos de pacientes pree-
clámpticas con embarazadas normotensas.
Materiales y métodos: Se seleccionaron 100 pacien-
tes que acudieron al Hospital Central “Dr. Urquinaona”, 
Maracaibo, Venezuela. Los grupos consistieron en pree-
clámpticas (grupo A; n = 50) y embarazadas normotensas 
sanas (grupo B; n = 50), consideradas como controles. Se 
evaluaron las concentraciones de lípidos - lipoproteínas 
maternas y neonatales.
Resultados: No se encontraron diferencias estadística-
mente significativas con relación a la edad materna y al 
índice de masa corporal materno entre ambos grupos (p = 
ns), pero si con respecto a la edad gestacional al momento 
del parto, presión arterial y proteinuria en 24 horas (p < 
0,0001). Los neonatos del grupo A presentaron valores 
significativamente más bajos de colesterol y lipoproteínas 
de alta densidad comparados con los neonatos del grupo 
B (p < 0,0001). Las concentraciones de triglicéridos fueron 
más elevadas en los neonatos del grupo A comparado con 
aquellos del grupo B (p < 0,0001). Las concentraciones de 
lipoproteínas de baja densidad no mostraron diferencias 
significativas entre los dos grupos (p = 0,1224). No se ob-
servó correlaciones significativas entre las concentraciones 
de lípidos - lipoproteínas maternos y neonatales en el gru-
po A (p = ns).
Conclusión: Los recién nacidos de pacientes preeclámp-
ticas tienen concentraciones significativamente más bajas 
de colesterol y lipoproteínas de alta densidad y concentra-
ciones más altas de triglicéridos comparado con los recién 
nacidos de embarazadas normotensas sanas.
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Objective: To compare plasma lipids and lipoprotein con-
centrations in newborn of preeclamptic patients with nor-
motensive pregnant women.
Materials and method: A total of 100 patients were se-
lected who assisted to Hospital Central “Dr. Urquinaona”, 
Maracaibo, Venezuela. Groups consisted in preeclamp-
tic patients (group A; n = 50) and healthy normotensive 
pregnant women (group B; n = 50) considered as controls. 
Maternal and neonatal lipids and lipoprotein concentra-
tions were evaluated.
Results: There were not found significant differences 
related to maternal age and body mass index between 
groups (p = ns), significant differences were found in 
gestational age at time of delivery, blood pressure and 
24-hour protein (p< 0.0001). Newborns of group A pre-
sented significant lower values of cholesterol and high-
density lipoprotein compared to newborns of group B 
(p<0.0001). Triglyceride concentrations were higher in 
newborn of group A compared to those in group B (p 
<0.0001). Low-density lipoprotein concentrations did 
not show significant difference between groups (p = ns). 
There were not observed significant correlation between 
maternal and neonatal lipids - lipoprotein concentrations 
in group A (p = ns).
Conclusion: Newborns of preeclamptic patients have 
lower concentrations of cholesterol and high-density li-
poprotein and higher concentrations of triglycerides com-
pared to newborns of healthy normotensive pregnant 
women.
Keywords: Lipids, Lipoproteins, Newborn, Preeclampsia.
Plasma lipids and lipoproteins 
in newborns of preeclamptic patients 
and normotensive pregnant women
Eucaris Andrade-Finol1, Eduardo Reyna-Villasmil1, Jorly Mejia-Montilla1, Joel-Santos-Bolívar1, Duly Torres-Cepeda1, Nadia Reyna-Villasmil2, Sandra Wilches-Durán, MgSc3, 
Modesto Graterol, MgSc, PhD3, Julio Contreras-Velásquez, MgSc3, Marco Cerda, MgSc3
1Department of obstetrics and Gynecology – Maternidad “Dr. Nerio Belloso”. Hospital Central “Dr. Urquinaona”. Maracaibo, Zulia state. Venezuela
2Research Center for Endocrine - Metabolic Disorders. Medicine Faculty. Universidad del Zulia.
3Advanced Frontier Studies Research Group (ALEF). Universidad Simón Bolívar, sede Cúcuta, Colombia
Correspondence to: Dr. Eduardo Reyna-Villasmil. Hospital Central “Dr. Urquinaona” El Milagro Avenue. Maracaibo, Zulia State. VENEZUELA. Phone number: 584162605233 
e-mail: sippenbauch@gmail.com
A
b
st
ra
ct
R
es
u
m
en
 
Lípidos y lipoproteínas plasmáticas en neonatos de pacientes preeclámpticas y de embarazadas normotensas
50
n normal pregnancies without complications there 
are changes in the lipid profile. A gestational incre-
ment of 300% has been described in the concen-
trations of triglycerides (TG), 25-50% of total cholesterol 
and variations in the concentrations of high density lipo-
proteins (HDL-C) and low density lipoproteins (LDL-C)1. The 
physiological basis for this gestational alteration is the nu-
trient supply to the rapidly growing fetus and the maternal 
energy needs2. The placental transportation of cholesterol 
is possible through the uptake of LDL-C by a receiver on 
the maternal side. The maternal TG is hydrolyzed by lipo-
protein lipase and transported through the placenta by the 
proteins that bind to fatty acids3-5. Hypertension syndrome 
during pregnancy is a specific multi-systemic disorder of 
pregnancy in humans and a maternal-fetal morbidity and 
mortality cause. The specific etiology is still unknown. It 
has been reported that in preeclamptic there is an altera-
tion of the lipid profile, activation of leukocytes, increment 
of the inflammatory response and oxidative stress in the 
maternal circulation6-8. The hypoperfused placenta is the 
potential source of reactive oxygen species and cytokines 
that can induce maternal inflammatory response9.
During preeclampsia, TG concentrations increase com-
pared to what is observed in normal pregnancy, especially 
in the third trimester1,10. Concentrations of HDL-C reduce 
as a result of TG concentrations. The change of lipopro-
tein concentrations during preeclampsia is considered an 
adaptive response to the placental failure1.
Few studies have focused on the circulatory changes such 
as biochemists in fetuses and newborn infants in pre-
eclamptic women. Previous studies have shown that pre-
eclampsia is associated with changes in the endothelial 
function of the fetal circulation6. However, there is little 
literature cited about the concentrations of lipids and li-
poproteins in newborns of preeclamptic patients; there-
fore, the aim of this research was to compare the plasma 
concentrations of lipids and lipoproteins in preeclamptic 
patients with normotensive pregnant women.
 study of cases and controls was car-
ried out from January 2014 to June 
2015, which included patients with 
simple pregnancies referred to the Hospital Central “Dr. 
Urquinaona”, Maracaibo, Venezuela. A total of 100 preg-
nant women and their newborns were selected. Fifty pre-
eclamptic and their newborns were included (group A) 
and a control group selected by having an age and body 
mass index similar to the study group, and consisted on 
50 healthy pregnant women and their newborns (Group 
B). The research was approved by the Ethics Committee 
and Research of the hospital and a written consent of all 
patients was obtained.
Pregnant women with polyhydramnios, third trimester 
bleedings (placenta abruptio, placenta praevia), suspect of 
the intrauterine fetal growth restriction (head circumfer-
ence, abdominal girth and femur length under 10 percent 
of reference with postnatal weight confirmation less than 
10 percent of reference), HELLP syndrome, fetal heart rate 
abnormalities, multiple gestations, active maternal or in-
trauterine infection, chronic hypertensive disease (before 
20 weeks of pregnancy), treatment with antihypertensive 
drugs, cardiac, liver or renal disease, pre or gestational 
diabetes mellitus, those pregnant women or newborns 
in which blood samples cannot be obtained and patients 
who have used drugs which alter plasma lipid concentra-
tion and smoking habit, were excluded. Also, patients 
who have refused to participate in the research were ex-
cluded. Preeclampsia was defined as systolic blood pres-
sure of 140 mm Hg or more or diastolic blood pressure 
of 90 mm Hg or more, confirmed for 6 hours or more of 
difference, while the proteinuria is defined as 300 mg or 
more of protein in a 24-hour sample, or 1-2 proteinuria 
crosses in a qualitative examination after 20 weeks of ges-
tation. Blood pressure was measured in the sitting posi-
tion after 15 minutes of rest using a 14 cm-sleeve stan-
dard mercury upper-arm device. The systolic and diastolic 
blood pressure (taken in relation to the fifth Korotkoff 
sound) was compared to the 2 mm Hg nearest point. The 
palpatory method was used to verify the auscultation of 
systolic blood pressure readings. The systolic and diastolic 
blood pressures were calculated from the average of the 
blood pressure in each arm.
Blood samples (10 ml) were collected from the antecubital 
vein in all patients before giving birth and immediately 
after the diagnosis, and the sample was clotted at room 
temperature. Twenty milliliters of blood were placed in a 
tube with K2 acetic acid (1 mg/ml final concentration) and 
heparin. In the newly born the blood sample was obtained 
(5 ml) immediately after the birth. Plasma was stored at 
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-80°C, centrifuged at low speed and lipid and lipoprotein 
measures were done immediately after.
Plasma total cholesterol, TG and HDL-C measurements 
were performed by a modification of the standard pro-
tocol of research clinic of lipids, using enzymatic reagents 
for determining the lipids. Total cholesterol and TG were 
measured using automate enzymatic methods (COBAS® 
integrate cholesterol and COBAS® integrate triglycerides) 
on a Roche/Hitachi® 74 Analyzer. The concentrations of 
HDL-C were determined after the selective precipitation 
using manganese-heparin and after the enzymatic de-
termination of cholesterol. The concentrations of LDL-C 
were calculated using the Friedwald formula (LDL-C = 
cholesterol - HDL-C - (TG/5)).
The data is presented as mean values ±standard deviation. 
The statistical analysis of the two groups was performed 
with the inference statistical test for unrelated data to 
compare the demographic characteristics and the lipid 
and lipoprotein concentrations. Pearson test was used 
to establish the correlations between maternal and new-
born concentrations of lipids and lipoproteins. It was also 
used to establish the relationship between the lipid and 
lipoprotein concentrations and the weight of newborns. 
P<0.05 was considered statistically significant.
he characteristics of preeclamptic women 
(group A) and normotensive pregnant women 
(group B) are shown in table 1. Statistically sig-
nificant differences were not found in relation to the age 
and maternal body mass index (p = ns), but there were 
observed in the gestational age at the time of delivery, 
the systolic and diastolic blood pressure and 24-hour 
proteinuria (p<0.0001). It was observed that newborns 
of the patients from group A presented average weights 
significantly lower than newborn of pregnant women 
from group B (2872 ±309 grams compared to 3635 ±369 
grams; p<0.0001).
Table 1. General characteristics
GROUP A
Cases
(n = 50)
GROUP B
Controls
(n = 50) p
Age/years 21.4 ± 3.0 22.1 ± 3.4 0.2777
Gestational age at the 
moment of the delivery, weeks 36.4 ± 1.1 38.3 ± 1.1 < 0.0001
Body mass index, Kg/m2 28.8 ± 2.0 28.9 ± 1.6 0.7831
Systolic blood pressure, mm 
de Hg
152.6 ± 
18.2
119.2 ± 
11.9 < 0.0001
Diastolic blood pressure, 
mm de Hg 96.6 ± 8.0 71.1 ± 9.0 < 0.0001
Proteinuria, g/24 horas 4.06 ± 1.87 0.12 ± 0.05 < 0.0001
Weight of the newborn, 
grams 2872 ± 309 3635 ± 369 < 0.0001
Table 2 shows the values of maternal and neonatal lipids 
and lipoproteins of the patients and infants in each group. 
The concentrations of cholesterol, TG, HDL-C and LDL-C 
were significantly more elevated in patients of group A 
compared to the patients of group B (p<0.0001). New-
borns in group A had significantly lower values of cho-
lesterol and HDL-C (74.9 ±10.4 mg/dL and 32.1 ± 3.6 
mg/dL, respectively) compared to newborns of group B 
(89.3 ±10.7 mg/dL and 52.7 ± 2.8 mg/dL, respectively; 
p<0.0001). TG concentrations were higher in newborns 
of group A compared to those of group B (47.1 ± 8.0 mg/
dL compared to 38.8 ± 6.4 mg/dL; p<0.0001). LDL-C con-
centrations did not show significant differences between 
the two groups (p = 0.1224).
Table 2. Maternal and neonatal lipid profile
GROUP A
Cases
(n = 50)
GROUP B
Controls
(n = 50) p
Maternal
Cholesterol, mg/dL 311.0 ± 24.3 260.1 ± 26.9 < 0.0001
Triglycerides, mg/dL 342.1 ± 39.4 216.4 ± 29.1 < 0.0001
HDL-C, mg/dL 56.2 ± 3.8 50.2 ± 2.2 < 0.0001
LDL-C, mg/dL 181.8 ± 20.9 156.9 ± 24.0 < 0.0001
Newborn
Cholesterol, mg/dL 74.9 ± 10.4 89.3 ± 10.7 < 0.0001
Triglycerides, mg/dL 47.1 ± 8.0 38.8 ± 6.4 < 0.0001
HDL-C, mg/dL 32.1 ± 3.6 52.7 ± 2.8 < 0.0001
LDL-C, mg/dL 39.3 ± 6.7 37.1 ± 7.4 0.1224
Significant correlations between the concentrations of 
cholesterol, TG and HDL-C were observed in all subjects 
of both groups (p<0.05) by correlating the concentrations 
of lipids and lipoproteins with maternal and fetal concen-
trations (table 3), but this correlation proved to be signifi-
cant when they were analyzed in the group of cases and 
in the control groups, which may be due, in part, to the 
small number of cases in both groups (p = ns). The weight 
of newborn of preeclamptic women only showed weak, 
negative and significant correlation with concentrations 
of LDL-C neonatal (Figure 5; r = -0.299; p<0.05).
Table 3. Correlations in the parameters of the 
maternal/newborn lipid profile
Both groups Controls Cases
Cholesterol - 0.302* 0.143 0.199
Triglycerides 0.388* 0.067 - 0.221
HDL-C - 0.664* - 0.195 0.065
LDL-C 0.146 - 0.109 0.052
* p < 0.05.
he results of this research confirm changes in 
the concentrations of lipids and lipoproteins in 
newborns of preeclamptic women compared 
to newborns of healthy normotensive pregnant women. 
On the other hand, the data from this current research 
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confirm previous findings of low concentrations of lipids 
in the newborns compared to maternal concentrations4,5.
Normal pregnancy is associated with physiological hyper-
lipidemia, which is emphasized in preeclampsia11. In this 
research, preeclamptic women showed significantly high-
er values of TG compared to normal pregnant women. 
Different authors have reported that TG concentrations in 
preeclampsia may lead to an “atherogenic state” 12,13. It 
has also been described that the increment of TG concen-
trations is a risk factor for cardiovascular disease14.
Maternal TG does not cross the placental barrier, but the 
TG on maternal lipoproteins is hydrolyzed by lipase-pla-
cental lipoprotein and the resulting fatty acids are trans-
ferred across the placenta by proteins that bind to fatty 
acids. The positive regulation of this mechanism may in-
crease the transport of fatty acids through the placenta to 
provide substrate to the fetal liver for the synthesis of TG3,15. 
Reaching the fetal circulation non- esterified fatty acids can 
be transported to the fetal liver for the synthesis of TG3.
The findings of this research show the tendency to mater-
nal hypertriglyceridemia and high concentrations of LDL-
C in preeclamptic women compared to healthy controls, 
which has previously been reported10,12,16. Obesity is as-
sociated with dyslipidemia and abdominal-visceral fat cor-
relates with increased plasma concentrations of TG and a 
decrease of HDL-C concentrations17. Body mass index is a 
risk factor for the development of preeclampsia and due 
to the influence of the body mass index on plasma lipids in 
pregnancy18,19. In this research, this possible confusing ele-
ment was limited. It could be demonstrated by controlling 
the effects of the body mass rate on the lipid profile that 
the concentrations of lipids and lipoproteins in infants are 
affected by preeclampsia.
The metabolism of lipoproteins in the fetus is still un-
known. In the fetus, the metabolism of HDL-C is different 
from the metabolism in adults20. The HDL-C forms a com-
plex with the apoprotein E, the main acceptor of lipids and 
is captured by cells through the lipoprotein receptor. This 
movement of cholesterol plays an important role in the 
development of tissues. It is possible that maternal high 
concentrations of HDL-C may be involved in the transfer 
of cholesterol from the placenta to the fetal circulation by 
the ABCA1 transporter, which is highly expressed in this 
tissue21. HDL-C rich in apoprotein E is important in the re-
distribution of cholesterol from tissues, where they appear 
in high concentrations, to tissues that need cholesterol for 
the metabolic processes.
The increment of maternal lipids during preeclampsia may 
cause changes in the amount of lipids that cross the pla-
centa, leading to modifications in the concentrations of 
neonatal lipids and lipoproteins. It is known that human 
placenta expresses large quantities of lipoproteins recep-
tors and HDL-C receptors play an important role in the 
uptake of maternal lipoproteins for the steroid placental 
metabolism22,23. It has been shown that during the first tri-
mester, trophoblast cells express SR-BI (a receiver of HDL-
C) and it can work as effective supply route of cholesteryl 
esters of maternal lipoproteins to the fetal tissue24. It is 
important to mention that neonatal lipid profile did not 
provide significant correlations with values of maternal 
lipids and lipoproteins in preeclamptic women neither in 
normotensive pregnant women. This could indicate that 
the circulating concentrations of maternal lipids available 
for the placental uptake are not probably the main deter-
minant of the lipid profile of infants.
Changes in lipids of newborns may be an appropriate 
physiological response to an adverse intrauterine envi-
ronment. Transportation mechanisms can be modified to 
compensate the structural and oxidative damage of the 
placenta25,26. The concentration of lipids may alter due to 
an incomplete development or immaturity of biochemi-
cal processes involved in the metabolism. It has been re-
ported that newborns who are small for their gestational 
age present alterations in the use of the circulating TG, 
consistent with the peripheral fat depletion27. Alterations 
in the lipid profile in infants of preeclamptic women can 
be attributed to the response of acute and chronic stress. 
Long-term stress can alter the fetal production of hor-
mones such as cortisol, with effects on lipid metabolism.
The correlation observed between concentrations of LDL-
C with the weight of the newborn of preeclamptic pa-
tients can be explained by the persistent decrease in the 
activity of the receptors of LDL-C associated with altera-
tions in fetal liver growth16,22. Preeclampsia can lead to un-
der-nourishment of the secondary fetus to utero-placental 
vascular insufficiency). The fetus responds to this state 
(particularly during the third trimester) keeping the brain 
growth at the expense of body growth22. This affects the 
liver, which grows rapidly in the last quarter, and it seems 
that it also affects the metabolism of LDL-C16.
The data found in newborns of preeclamptic patients 
show high concentrations of cholesterol and TG with low 
concentrations of HDL-C. Therefore, the lipid profile of 
these infants would be, in relation to the group of control 
newborns, more atherogenic. These changes in the lipid 
profile of newborns of preeclamptic patients may have a 
negative effect during adulthood since it is related to the 
possible risk of atherosclerosis. Considering the changes 
in the lipid profile in this group of infants, it would be 
interesting to investigate if they have any difference in the 
risk factors compared to infants of normotensive preg-
nant women in a subsequent period. This can provide in-
formation about the metabolism of lipoproteins and, on 
the risk and importance of studying these subjects in the 
development of cardiovascular disease in adult life.
It is concluded that the infants of preeclamptic patients 
have significantly lower concentrations of cholesterol and 
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high-density lipoprotein, and higher concentrations of tri-
glycerides compared to newborns of normotensive preg-
nant patients.
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